GV20 Therapeutics uses its proprietary STEAD (Simultaneous Target Evaluation and Antibody Discovery) platform to decode the natural B cell responses in patient tumors to rapidly identify novel ...

NEW YORK--(BUSINESS WIRE)--Plural, the next-generation Kubernetes management platform, has secured $6M ... transformed how enterprises deploy and scale containerized applications," said Sean ...

The First Lightning Payments Provider Fully Integrated with an Enterprise Crypto Compliance Platform AUSTIN ... their ...